Info banner

A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Transforming the workers’ compensation pharmacy and ancillary benefits management experience

Supported by human-centered service

Informed by industry expertise

Inspired by a commitment to care

blog

6 Complexities in Workers’ Comp Claims – and How to Address Them

Let’s look at common complexities in workers’ comp claims – and how a combination of technology, data, and people can help address them.

rxinformer

The Heart of the Matter: Pharmacy Considerations for Cardiovascular Comorbidities

128 million adults in the U.S. are affected by hypertension and cardiovascular diseases.

INDUSTRY SURVEY

2025 Industry Survey Report

This seventh annual survey report highlights the top challenges and priorities of 500 industry professionals.

Jeanette Connelly, PharmD, a clinical pharmacist at Healthesystems, discusses safety and cost concerns associated with physician dispensing practices in workers' compensation.

Opioids & Pain Management

Personalize my experience

Make selections below to see articles and information related to your role and interests.

RxInformer

By the Numbers: 15 RxInformer Stats for 15 Years

Now that RxInformer is officially 15, we looked back at past issues to gather interesting stats about the magazine and how it’s produced.

Summer 2025

RxInformer

Burden of Proof: Unpacking Presumptions in Workers’ Comp

New presumptions in workers’ comp are making it easier for workers to qualify for benefits related to mental injury, including PTSD, as well as certain cancers and other conditions.

Summer 2025

RxInformer

Then and Now: Reflections from 15 Years of RxInformer

The editorial staff looked back at past issues to understand what has changed – and what hasn’t

Summer 2025

RxInformer

Pain Points: Chronic Pain and the Injured Worker

Chronic pain affects millions and has direct consequences for injured workers and in the workplace, from absenteeism to higher healthcare costs.

Summer 2025

RxInformer

A Splitting Headache: Trends in Migraine Therapy

Migraine drugs make up a growing portion of pharmacy spend, driven by newer CGRP antagonists

Summer 2025

RxInformer

Concerning Counsel: A Look at Litigation in Workers’ Comp

An examination of the causes and impact regarding attorney representation in workers' compensation

Summer 2025

RxInformer

State of the Nation

A perspective penned by our VP of Industry and State Affairs

Summer 2025

Clinical Insights

JAMA Finds High Prevalence of Depression and Anxiety in Chronic Pain Patients

A systematic review of 376 studies comprising almost 350,000 people with chronic pain saw 40% prevalence rates for depression and anxiety.

Apr 2025

This Month's Must Read

Digital Therapeutics: The Promise of Better Health Outcomes for Injured Workers

What they are, the benefits, how they’re currently covered by insurers, and future outlooks.

Apr 2025

Marijuana Developments

Massachusetts Considers Reimbursement, California Could Reject Medical Recommendation

A bill in Massachusetts could require insurers to pay for marijuana, while ACOEM recommends against marijuana for chronic pain guidelines.

Apr 2025

Clinical Insights

WCRI Publishes Study on Degenerative and Comorbid Conditions

Approximately 38.8% of claims had one or more comorbidities, based on an analysis of 930,000 claims with at least 7 days lost time across 32 states.

Apr 2025

Healthe Developments

Video Spotlight: How Obesity Can Complicate Workplace Injuries

Silvia Sacalis, VP of Clinical Services, chats with Business Insurance.

Apr 2025

Healthe Developments

Visit Healthesystems at RISKWORLD 2025

Drop by Booth #824 for a copy of the 15th Anniversary edition of RxInformer magazine, and to learn how we’re transforming healthcare.

Apr 2025

Blog

4 Questions with Mike Theis, AVP of Product Analytics & Business Strategy

Mike Theis, Healthesystems’ AVP of Product Analytics & Business Strategy, discusses the evolving role of analytics in workers’ comp managed care programs

Mar 2025

Medmonitor

FDA Declares Semaglutide Shortage Over

The GLP-1 receptor agonist has been considered in shortage since 2022, but the FDA confirmed with manufacturers that presented and projected demand can now be met.